These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16185170)

  • 1. Clevudine for the treatment of chronic hepatitis B virus infection.
    Hui CK; Lau GK
    Expert Opin Investig Drugs; 2005 Oct; 14(10):1277-84. PubMed ID: 16185170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
    Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
    Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression.
    Yoo BC; Kim JH; Kim TH; Koh KC; Um SH; Kim YS; Lee KS; Han BH; Chon CY; Han JY; Ryu SH; Kim HC; Byun KS; Hwang SG; Kim BI; Cho M; Yoo K; Lee HJ; Hwang JS; Kim YS; Lee YS; Choi SK; Lee YJ; Yang JM; Park JW; Lee MS; Kim DG; Chung YH; Cho SH; Choi JY; Kweon YO; Lee HY; Jeong SH; Yoo HW; Lee HS
    Hepatology; 2007 Oct; 46(4):1041-8. PubMed ID: 17647293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection.
    Korba BE; Cote PJ; Menne S; Toshkov I; Baldwin BH; Wells FV; Tennant BC; Gerin JL
    Antivir Ther; 2004 Dec; 9(6):937-52. PubMed ID: 15651753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus.
    Zhu Y; Cullen JM; Aldrich CE; Saputelli J; Miller D; Seeger C; Mason WS; Jilbert AR
    Virology; 2004 Sep; 327(1):26-40. PubMed ID: 15327895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clevudine: a promising therapy for the treatment of chronic hepatitis B.
    Asselah T; Lada O; Moucari R; Marcellin P
    Expert Opin Investig Drugs; 2008 Dec; 17(12):1963-74. PubMed ID: 19012511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment efficacy of clevudine, entecavir and lamivudine in treatment-naive patients with HBeAg-positive chronic hepatitis B].
    Bae SH; Baek YH; Lee SW; Han SY
    Korean J Gastroenterol; 2010 Dec; 56(6):365-72. PubMed ID: 21173560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term clevudine therapy in nucleos(t)ide-naïve and lamivudine-experienced patients with hepatitis B virus-related chronic liver diseases].
    Lee HJ; Eun JR; Lee CH; Hwang JS; Suh JI; Kim BS; Jang BK
    Korean J Hepatol; 2009 Jun; 15(2):179-92. PubMed ID: 19581770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of clevudine resistance after switching from lamivudine in a patient with chronic hepatitis B].
    Koh KH; Kang CJ; Kim DH; Choi YW; Kim MJ; Cheong JY; Cho SW
    Korean J Gastroenterol; 2008 Nov; 52(5):325-8. PubMed ID: 19077481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of clevudine-resistant mutants of hepatitis B virus isolated from chronic hepatitis B patients.
    Kwon SY; Park YK; Ahn SH; Cho ES; Choe WH; Lee CH; Kim BK; Ko SY; Choi HS; Park ES; Shin GC; Kim KH
    J Virol; 2010 May; 84(9):4494-503. PubMed ID: 20164224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clevudine: a potent inhibitor of hepatitis B virus in vitro and in vivo.
    Korba BE; Furman PA; Otto MJ
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):549-61. PubMed ID: 17009935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between clevudine and entecavir treatment for antiviral-naïve patients with chronic hepatitis B.
    Kim HJ; Park DI; Park JH; Cho YK; Sohn CI; Jeon WK; Kim BI
    Liver Int; 2010 Jul; 30(6):834-40. PubMed ID: 20408946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B.
    Yoo BC; Kim JH; Chung YH; Lee KS; Paik SW; Ryu SH; Han BH; Han JY; Byun KS; Cho M; Lee HJ; Kim TH; Cho SH; Park JW; Um SH; Hwang SG; Kim YS; Lee YJ; Chon CY; Kim BI; Lee YS; Yang JM; Kim HC; Hwang JS; Choi SK; Kweon YO; Jeong SH; Lee MS; Choi JY; Kim DG; Kim YS; Lee HY; Yoo K; Yoo HW; Lee HS
    Hepatology; 2007 May; 45(5):1172-8. PubMed ID: 17464992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of viral hepatitis B.
    Pramoolsinsup C
    J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection.
    Jacquard AC; Nassal M; Pichoud C; Ren S; Schultz U; Guerret S; Chevallier M; Werle B; Peyrol S; Jamard C; Rimsky LT; Trepo C; Zoulim F
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2683-92. PubMed ID: 15215126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of 48-week clevudine therapy for chronic hepatitis B].
    Kim MH; Kim KA; Lee JS; Lee HW; Kim HJ; Yun SG; Kim NH; Bae WK; Moon YS
    Korean J Hepatol; 2009 Sep; 15(3):331-7. PubMed ID: 19783882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-week clevudine therapy showed potent and durable antiviral activity in HBeAg-positive chronic hepatitis B.
    Lee HS; Chung YH; Lee K; Byun KS; Paik SW; Han JY; Yoo K; Yoo HW; Lee JH; Yoo BC
    Hepatology; 2006 May; 43(5):982-8. PubMed ID: 16628625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of entecavir switching therapy in chronic hepatitis B patients with clevudine-induced myopathy].
    Lee JW; Lee YJ; Lee JJ; Kim JH; Jung YK; Kwon OS; Choi DJ; Kim YS; Kim JH
    Korean J Gastroenterol; 2013 Jan; 61(1):30-6. PubMed ID: 23354347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clevudine for hepatitis B.
    Anderson DL
    Drugs Today (Barc); 2009 May; 45(5):331-50. PubMed ID: 19584963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.